These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 22332936)

  • 1. Nanoparticles disguised as red blood cells to evade the immune system.
    Fang RH; Hu CM; Zhang L
    Expert Opin Biol Ther; 2012 Apr; 12(4):385-9. PubMed ID: 22332936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes.
    Chambers E; Mitragotri S
    J Control Release; 2004 Nov; 100(1):111-9. PubMed ID: 15491815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coating nanoparticles with cell membranes for targeted drug delivery.
    Gao W; Zhang L
    J Drug Target; 2015; 23(7-8):619-26. PubMed ID: 26453159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long circulating nanoparticles via adhesion on red blood cells: mechanism and extended circulation.
    Chambers E; Mitragotri S
    Exp Biol Med (Maywood); 2007 Jul; 232(7):958-66. PubMed ID: 17609513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors.
    McNeeley KM; Karathanasis E; Annapragada AV; Bellamkonda RV
    Biomaterials; 2009 Aug; 30(23-24):3986-95. PubMed ID: 19427688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems.
    Villa CH; Anselmo AC; Mitragotri S; Muzykantov V
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):88-103. PubMed ID: 26941164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythrocytes-based synthetic delivery systems: transition from conventional to novel engineering strategies.
    Bhateria M; Rachumallu R; Singh R; Bhatta RS
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1219-36. PubMed ID: 24912015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte-inspired delivery systems.
    Hu CM; Fang RH; Zhang L
    Adv Healthc Mater; 2012 Sep; 1(5):537-47. PubMed ID: 23184788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red blood cells based nanotheranostics: A smart biomimetic approach for fighting against cancer.
    Misra R; Sanjana Sharath N
    Int J Pharm; 2024 Aug; 661():124401. PubMed ID: 38986966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform.
    Hu CM; Zhang L; Aryal S; Cheung C; Fang RH; Zhang L
    Proc Natl Acad Sci U S A; 2011 Jul; 108(27):10980-5. PubMed ID: 21690347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges and advances in nanoparticle-based oral insulin delivery.
    Ramesan RM; Sharma CP
    Expert Rev Med Devices; 2009 Nov; 6(6):665-76. PubMed ID: 19911877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEGylated liposomal doxorubicin targeted to α5β1-expressing MDA-MB-231 breast cancer cells.
    Shroff K; Kokkoli E
    Langmuir; 2012 Mar; 28(10):4729-36. PubMed ID: 22268611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell membrane biomimetic nanoparticles for inflammation and cancer targeting in drug delivery.
    Wang H; Liu Y; He R; Xu D; Zang J; Weeranoppanant N; Dong H; Li Y
    Biomater Sci; 2020 Jan; 8(2):552-568. PubMed ID: 31769765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Size Dependency of Circulation and Biodistribution of Biomimetic Nanoparticles: Red Blood Cell Membrane-Coated Nanoparticles.
    Li H; Jin K; Luo M; Wang X; Zhu X; Liu X; Jiang T; Zhang Q; Wang S; Pang Z
    Cells; 2019 Aug; 8(8):. PubMed ID: 31412631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [PEG-liposome in DDS and clinical studies].
    Maruyama K
    Nihon Rinsho; 1998 Mar; 56(3):632-7. PubMed ID: 9549348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gold nanoparticles generated and stabilized by water soluble curcumin-polymer conjugate: blood compatibility evaluation and targeted drug delivery onto cancer cells.
    Manju S; Sreenivasan K
    J Colloid Interface Sci; 2012 Feb; 368(1):144-51. PubMed ID: 22200330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomimetic nanoarchitecturing: A disguised attack on cancer cells.
    Jha A; Nikam AN; Kulkarni S; Mutalik SP; Pandey A; Hegde M; Rao BSS; Mutalik S
    J Control Release; 2021 Jan; 329():413-433. PubMed ID: 33301837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects.
    Yoo JW; Chambers E; Mitragotri S
    Curr Pharm Des; 2010 Jul; 16(21):2298-307. PubMed ID: 20618151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of superparamagnetic CaCO3 mesocrystals for multistage delivery in cancer therapy.
    Zhao Y; Lu Y; Hu Y; Li JP; Dong L; Lin LN; Yu SH
    Small; 2010 Nov; 6(21):2436-42. PubMed ID: 20878636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.